In a new set of guidelines, the U.S. Multi-Society Task Force on Colorectal Cancer offers various approaches to the diagnosis and management of cancer risk in patients with gastrointestinal ...

The High Risk GI Cancer Clinic at Huntsman Cancer Institute is for people with a higher chance of getting gastrointestinal (GI) polyps and GI cancers due to genetic mutations or a family history of ...

A male patient in his mid-thirties with a personal and family history of polyps underwent duodenal polypectomy. Peutz-Jeghers syndrome (PJS) is a rare, autosomal dominant hamartomatous polyposis ...

Bethesda, Maryland (April 26, 2022) – Gastrointestinal hamartomatous polyposis syndromes are rare, hereditary disorders associated with an increased risk of colorectal cancer. The U.S. Multisociety ...

Undergoing cancer treatment at a younger age can put the survivors at risk of developing numerous gastrointestinal polyps, even if they do not have hereditary susceptibility to polyposis. The acquired ...

Cronkhite–Canada Syndrome (CCS) is a rare, nonhereditary disorder distinguished by diffuse gastrointestinal polyposis and accompanying ectodermal manifestations such as alopecia, skin ...

You may not have heard of Juvenile Polyposis Syndrome -- a rare genetic disorder that's a real danger to kids and teens, putting them more at risk for colorectal and other cancers. It's why we're ...

Simpson's Paradox and the Impact of Different DNMT3A Mutations on Outcome in Younger Adults With Acute Myeloid Leukemia We developed a decision model to evaluate NGS panel testing compared with ...

Please provide your email address to receive an email when new articles are posted on . “The gastrointestinal hamartomatous polyposis syndromes are rare, autosomal dominant disorders associated with ...

Cronkhite-Canada syndrome (CCS) is a rare, non-hereditary condition that causes multiple noncancerous polyps in the digestive tract and changes in the skin, hair, and nails. Cronkhite-Canada syndrome ...

We developed a decision model to evaluate NGS panel testing compared with current standard of care in patients referred to a cancer genetics clinic. We obtained data on the prevalence of genetic ...